Tempest Therapeutics Inc. (NASDAQ: TPST)
$2.21
-0.0150 ( -0.68% ) 161.2K
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
Market Data
Open
$2.21
Previous close
$2.22
Volume
161.2K
Market cap
$48.88M
Day range
$2.20 - $2.26
52 week range
$0.17 - $9.77
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | Nov 08, 2023 |
8-k | 8K-related | 12 | Oct 30, 2023 |
4 | Insider transactions | 1 | Oct 13, 2023 |
4 | Insider transactions | 1 | Oct 13, 2023 |
4 | Insider transactions | 1 | Oct 13, 2023 |
4 | Insider transactions | 1 | Oct 13, 2023 |
8-k | 8K-related | 18 | Oct 11, 2023 |
8-k | 8K-related | 12 | Sep 08, 2023 |
8-k | 8K-related | 12 | Sep 07, 2023 |
10-q | Quarterly Reports | 61 | Aug 10, 2023 |